Effect Of Oral Phytoestrogen On Androgenicity And Insulin Sensitivity In Postmenopausal Women
| Effect | None |
| Trial Design | Double blind |
| Trial Length | 1-6 months |
| Number of Subjects | 43 |
| Gender | Female |
| Age Range | 45-64 |
| Body Types | Overweight |
Supplementation of 40-80mg of Promensil daily for three months in healthy postmenopausal women failed to significantly influence circulating hormones, but appeared to reduce insulin sensitivity as assessed by QUICKI.
Effects Of A Red Clover Extract (MF11RCE) On Endometrium And Sex Hormones In Postmenopausal Women
| Effect | Increase |
| Trial Design | Double blind |
| Trial Length | 1-6 months |
| Number of Subjects | 109 |
| Gender | Female |
| Age Range | 45-64 |
| Body Types | Average |
In postmenopausal women given the isoflavone supplement (MF11RCE) at 40mg twice daily for a period of 90 days, supplementation failed to influence estrogen or SHBG but appeared to increase testosterone concentrations in serum (22%) and decreased endometrial thickness.
| Effect | None |
| Trial Design | Double blind |
| Trial Length | 1-6 months |
| Number of Subjects | 53 |
| Gender | Female |
| Age Range | 45-64, 65+ |
| Body Types | Overweight, Average |
Supplementation of 80mg of red clover isoflavones daily to postmenopausal women for 90 days was able to reduce symptoms of menopause with minimal effects on the cardiovascular system nor the hormonal system.